LNK-005

N/A

Report date: 2025/04/11 13:35:41
NME

Base Information

Drug NameLNK-005
Drug Alias NameLNK-005
ClassificationOther
Mechanisms of ActionMitogen-activated protein kinase kinase kinase kinase 1 modulators
TargetsMitogen-activated protein kinase kinase kinase kinase 1
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesLynk Pharmaceutical (Hangzhou) Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesLynk Pharmaceutical (Hangzhou) Co Ltd
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A